Conditional reprogramming: Modeling urological cancer and translation to clinics

Area of Science:

• Oncology
• Stem Cell Biology
• Regenerative Medicine

Background:

• Patient-derived models are crucial for cancer research.
• Conditional reprogramming (CR) enables indefinite proliferation of primary cells without genetic modification.
• CRCs can mimic parental tumor phenotypes and genetic aberrations.

Purpose of the Study:

• To review the applications, limitations, and future potential of CRCs in modeling urological cancer.
• To highlight the utility of CRCs in basic and translational cancer research.
• To explore the use of CRCs in precision medicine and regenerative applications.

Main Methods:

• Utilizing a co-culture system with irradiated murine fibroblasts and a Rho-associated kinase inhibitor.
• Inducing stem cell properties and indefinite proliferation in primary human normal or tumor cells.
• Culturing malignant CRCs in vitro to maintain genetic and phenotypic fidelity to patient tumors.

Main Results:

• Malignant CRCs retain genetic aberrations and tumor phenotypes from parental specimens.
• Normal CRCs maintain normal karyotype and lineage commitment.
• CRCs show promise for studying cancer biology, discovering therapies, and advancing precision medicine.

Conclusions:

• CRCs are valuable patient-derived models for urological cancer research.
• The CR technique facilitates the study of cancer biology and the development of novel therapies.
• CRCs hold potential for toxicity testing, regenerative medicine, and clinical translation.